172 related articles for article (PubMed ID: 24964891)
21. Racial Disparities Exist in Outcomes After Major Fragility Fractures.
Wright NC; Chen L; Saag KG; Brown CJ; Shikany JM; Curtis JR
J Am Geriatr Soc; 2020 Aug; 68(8):1803-1810. PubMed ID: 32337717
[TBL] [Abstract][Full Text] [Related]
22. Hip fractures in Singapore: ethnic differences and temporal trends in the new millennium.
Yong EL; Ganesan G; Kramer MS; Logan S; Lau TC; Cauley JA; Tan KB
Osteoporos Int; 2019 Apr; 30(4):879-886. PubMed ID: 30671610
[TBL] [Abstract][Full Text] [Related]
23. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
[TBL] [Abstract][Full Text] [Related]
24. Trends in subtrochanteric, diaphyseal, and distal femur fractures, 1984-2007.
Ng AC; Drake MT; Clarke BL; Sems SA; Atkinson EJ; Achenbach SJ; Melton LJ
Osteoporos Int; 2012 Jun; 23(6):1721-6. PubMed ID: 21909727
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates and the risk of atypical femur fractures.
Black DM; Condra K; Adams AL; Eastell R
Bone; 2022 Mar; 156():116297. PubMed ID: 34920168
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women.
Park-Wyllie LY; Mamdani MM; Juurlink DN; Hawker GA; Gunraj N; Austin PC; Whelan DB; Weiler PJ; Laupacis A
JAMA; 2011 Feb; 305(8):783-9. PubMed ID: 21343577
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry.
Lee YK; Byun DW; Jung SM; Kwon HY; Kim HY; Kim SH; Kim TY; Jang S; Ha YC
Calcif Tissue Int; 2019 Mar; 104(3):313-319. PubMed ID: 30446771
[TBL] [Abstract][Full Text] [Related]
28. Recent trends in hip fracture rates by race/ethnicity among older US adults.
Wright NC; Saag KG; Curtis JR; Smith WK; Kilgore ML; Morrisey MA; Yun H; Zhang J; Delzell ES
J Bone Miner Res; 2012 Nov; 27(11):2325-32. PubMed ID: 22692958
[TBL] [Abstract][Full Text] [Related]
29. Decreased incidence of hip fracture in Hispanics, Asians, and blacks: California Hospital Discharge Data.
Silverman SL; Madison RE
Am J Public Health; 1988 Nov; 78(11):1482-3. PubMed ID: 3177728
[TBL] [Abstract][Full Text] [Related]
30. Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study.
Abrahamsen B; Eiken P; Eastell R
J Bone Miner Res; 2009 Jun; 24(6):1095-102. PubMed ID: 19113931
[TBL] [Abstract][Full Text] [Related]
31. Femur fracture classification in women with a history of breast cancer.
Chau S; Chandra M; Grimsrud CD; Gonzalez JR; Hui RL; Lo JC
J Bone Oncol; 2014 May; 3(2):49-53. PubMed ID: 26909297
[TBL] [Abstract][Full Text] [Related]
32. Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures.
Spangler L; Ott SM; Scholes D
Osteoporos Int; 2011 Sep; 22(9):2523-7. PubMed ID: 21153405
[TBL] [Abstract][Full Text] [Related]
33. Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older.
van der Velde RY; Wyers CE; Geusens PPMM; van den Bergh JPW; de Vries F; Cooper C; van de Staa TP; Harvey NC
Osteoporos Int; 2018 Nov; 29(11):2469-2475. PubMed ID: 30030587
[TBL] [Abstract][Full Text] [Related]
34. Hip and Subtrochanteric or Femoral Shaft Fractures after Bisphosphonate Use in Korean Women, Using Korean National Sample Cohort.
Won SH; Ahn S; Ji E; Park JW; Kim JK; Lee YK
J Korean Med Sci; 2020 Jun; 35(25):e193. PubMed ID: 32597040
[TBL] [Abstract][Full Text] [Related]
35. Ethnic differences in femur geometry in the women's health initiative observational study.
Nelson DA; Beck TJ; Wu G; Lewis CE; Bassford T; Cauley JA; LeBoff MS; Going SB; Chen Z
Osteoporos Int; 2011 May; 22(5):1377-88. PubMed ID: 20737265
[TBL] [Abstract][Full Text] [Related]
36. Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
Pazianas M; Abrahamsen B; Wang Y; Russell RG
Osteoporos Int; 2012 Dec; 23(12):2873-84. PubMed ID: 22431012
[TBL] [Abstract][Full Text] [Related]
37. Race and ethnic variation in proximal femur structure and BMD among older men.
Marshall LM; Zmuda JM; Chan BK; Barrett-Connor E; Cauley JA; Ensrud KE; Lang TF; Orwoll ES;
J Bone Miner Res; 2008 Jan; 23(1):121-30. PubMed ID: 17892375
[TBL] [Abstract][Full Text] [Related]
38. Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries.
Wang Z; Ward MM; Chan L; Bhattacharyya T
Osteoporos Int; 2014 Aug; 25(8):2109-16. PubMed ID: 24846316
[TBL] [Abstract][Full Text] [Related]
39. Association of trabecular bone score (TBS) and prior fracture differs among minorities in NHANES 2005-2008.
Jain RK; Vokes T
Osteoporos Int; 2018 Sep; 29(9):2093-2099. PubMed ID: 29858633
[TBL] [Abstract][Full Text] [Related]
40. [Study on the Effects of Sex and Age on Proximal Femoral Fractures in Two Culturally Diverse Countries].
Zelenka L; Knížková I; Lukešová D; Kunc P
Acta Chir Orthop Traumatol Cech; 2019; 86(5):330-333. PubMed ID: 31748107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
